These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2853067)

  • 21. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of dopamine-dependent adenylate cyclase activity in human renal cortex.
    Baldi E; Pupilli C; Amenta F; Mannelli M
    Eur J Pharmacol; 1988 May; 149(3):351-6. PubMed ID: 2900770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterisation of the dopamine-sensitive adenylate cyclase in cockroach brain: evidence for a distinct dopamine receptor.
    Orr GL; Gole JW; Notman HJ; Downer RG
    Life Sci; 1987 Dec; 41(25):2705-15. PubMed ID: 2892104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP-independent CGRP8-37-sensitive receptors mediate adrenomedullin-induced decrease of CaCl2-contraction in pregnant rat mesenteric artery.
    Ross GR; Yallampalli U; Yallampalli C
    J Vasc Res; 2008; 45(1):33-44. PubMed ID: 17898545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dopamine receptor activation on the level of cyclic AMP in the trabecular meshwork.
    Karnezis TA; Tripathi BJ; Dawson G; Murphy MB; Tripathi RC
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1090-4. PubMed ID: 2567286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic localization of dopamine receptors in rat cerebral blood vessels.
    Amenta F; Ricci A; Vega JA
    Eur J Pharmacol; 1991 Jan; 192(1):123-32. PubMed ID: 1828235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cyclic AMP-affecting agents on contractile reactivity of isolated mesenteric and renal resistance arteries of the rat.
    Heesen BJ; De Mey JG
    Br J Pharmacol; 1990 Dec; 101(4):859-64. PubMed ID: 1707706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptor.
    Berkowitz BA; Ohlstein EH
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S559-63. PubMed ID: 6210423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential.
    Prieto D; Buus C; Mulvany MJ; Nilsson H
    J Physiol; 1997 Jul; 502 ( Pt 2)(Pt 2):281-92. PubMed ID: 9263910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitonin gene-related peptide activated ATP-sensitive K+ currents in rabbit arterial smooth muscle via protein kinase A.
    Quayle JM; Bonev AD; Brayden JE; Nelson MT
    J Physiol; 1994 Feb; 475(1):9-13. PubMed ID: 8189394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of postsynaptic D1- and D2-dopamine receptors in the cardiovascular system.
    Missale C; Castelletti L; Memo M; Carruba MO; Spano PF
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):643-50. PubMed ID: 2457758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D1 dopamine receptors in the rat retina: effect of dark adaptation and chronic blockade by SCH 23390.
    Porceddu ML; De Montis G; Mele S; Ongini E; Biggio G
    Brain Res; 1987 Oct; 424(2):264-71. PubMed ID: 2960425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucocorticoids and dopamine-1 receptors on vascular smooth muscle cells.
    Yasunari K; Kohno M; Balmforth A; Murakawa K; Yokokawa K; Kurihara N; Takeda T
    Hypertension; 1989 Jun; 13(6 Pt 1):575-81. PubMed ID: 2472357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine-sensitive adenylate cyclase in rabbit portal vein.
    Amenta F
    Neurosci Lett; 1985 May; 56(3):279-82. PubMed ID: 2991823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat.
    Kerns WD; Arena E; Macia RA; Bugelski PJ; Matthews WD; Morgan DG
    Toxicol Pathol; 1989; 17(1 Pt 2):203-13. PubMed ID: 2568682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ontogeny of DA1 receptor-adenylate cyclase coupling in proximal convoluted tubules.
    Kinoshita S; Felder RA
    Am J Physiol; 1990 Dec; 259(6 Pt 2):F971-6. PubMed ID: 1979720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.